Shares of Teladoc Health Inc. (TDOC) soared 5.98% in Tuesday's trading session following the release of better-than-expected second-quarter results and an optimistic full-year outlook. The virtual healthcare provider demonstrated resilience in its core business despite ongoing challenges in its direct-to-consumer segment.
Teladoc reported a narrower loss of $0.19 per share for Q2, significantly beating analyst expectations of a $0.25-$0.26 loss. Revenue came in at $631.9 million, surpassing Wall Street estimates of around $623 million, although this represented a slight 2% year-over-year decline. The company's Integrated Care segment showed strength with a 4% revenue increase to $391.5 million, helping to offset a 9% decline in the BetterHelp segment.
Investors were particularly encouraged by Teladoc's full-year 2025 guidance, with the company projecting revenue between $2.501 billion and $2.548 billion, and adjusted EBITDA of $263 million to $294 million. Additionally, Teladoc secured a new five-year, $300 million senior secured revolving credit facility, which CEO Chuck Divita noted would "preserve and enhance our financial and operational flexibility." The company's focus on strategic priorities and disciplined execution appears to be resonating with the market, as it continues to navigate the evolving healthcare landscape.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.